FacebookTwitterRedditEmail

Stop Suicide By Helping Big Pharma, Says Shady Suicide Prevention Group

Next month, hundreds across the country will participate in “Out of the Darkness” walks to raise awareness about suicide and to support the American Foundation for Suicide Prevention (AFSP).

AFSP and similar groups like the National Alliance on Mental Illness (NAMI) and Active Minds claim there are “stigmas” and “barriers” to treatment for mental illness and there is not enough “awareness.” Two facts are missing in their messaging.

First, with as much as a fourth of some U.S. populations on antidepressants and ubiquitous quizzes and ads for them, there is neither a lack of “awareness” ––or are the drugs working. Why are suicides at an all time high at the same time psychoactive drug use is at an all time high?

Secondly, the groups are funded by Pharma to increase drug use and are widely considered unethical front groups, also called astroturf.

The American Foundation for Suicide Prevention, founded in 1987, is steeped in Pharma money. In 2008, AFSP merged with the Suicide Prevention Action Network USA or SPAN which had announced in 2004 that “SPAN USA’s efforts to develop and expand its suicide survivor network received a major boost with a recent grant from Eli Lilly and Company Foundation,” and “The foundation generously provided funding to support training, education and collaborative opportunities for SPAN USA’s existing network and enable further expansion into all 50 states.” No lack of transparency there.

In AFSP’s 2009 report, its leading donors were Pharma companies and it attributes a new screening project to “funding from Eli Lilly and Co., Janssen, Solvay Pharmaceuticals Inc. and Wyeth Pharmaceuticals.” It also credits Eli Lilly for printing its brochures. No lack of transparency there, either.

In 2011, AFSP appointed psychiatrist Charles Nemeroff president of the organization until his troubles began. Nemeroff became the subject of a congressional inquiry and was found to have so much unreported Pharma income, the $9.3 million National Institutes of Health (NIH) grant to study depression that he managed was suspended, which happens rarely. He left Emory University in disgrace.

A 1999 textbook written by Nemeroff and his colleague Alan Schatzberg was found, in 2010, to be written and funded by GlaxoSmithKline. Both Nemeroff and Schatzberg remain at AFSP and are termed “leaders.”

AFSP’s 2012 annual report reveals a $100,000 donation from Forest Laboratories, and donations from Eli Lilly, Pfizer and five other Pharma companies.

“AFSP also boasts the honor of having a former president – David Shaffer – who was responsible for leading the development of the now somewhat infamous TeenScreen,” writes Mad in America. “TeenScreen is a controversial tool that Marcia Angell (Harvard Professor and former editor-in-chief of the New England Journal of Medicine)…described as, “just a way to put more people on prescription drugs.

The now defunct TeenScreen which screened young people for early signs of depression had “ties to the pharmaceutical industry,” reported the Scientific American.

Screening and intervention are widely accepted now to be nothing but sales tools—even to the mainstream medical establishment. In “How We Do Harm,” Dr. Otis Brawley, chief medical and scientific officer of the American Cancer Society and an oncologist, devotes a chapter to how prostate screening is often done just for money sometimes with disastrous and deadly results.

AFSP’s annual report names Pharma companies Sunovion, Janssen, Forest, Pfizer and Otsuka America Pharmaceuticals as financial donors. AFSP also named Phil Satow, former Forest executive, to its Project 2025 Advisory Committee. Satow has worked for many Pharma companies and is co-founder and board chair of the very pro-drug JED Foundation.

Preventing Suicides or Causing Them?

While SSRIs can be useful in some depressions, they can also cause suicide–a fact written clearly on all their package inserts. In 2005, after meeting with parents whose children killed themselves on the drugs and public health officials, the FDA attached the following “Black Box” warning to SSRI antidepressants.

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of PAXIL [one SSRI] or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.

One chilling demonstration of the danger to young adults is seen in the military where SSRI use and suicides have reached astounding proportions. More than a third of the deaths were in soldiers who never deployed so combat stress was not a factor.

Both NAMI and Active Minds swoop down on campuses after suicides to suggest that not enough antidepressants are being prescribed–despite the clear dangers posed for that age group and sometimes without knowing if the victim was already on the pushed drugs. To remove the fabricated stigma to mental problems, Pharma funded groups visit public schools to suggest more young people should be on drugs. They even produce posters with the message that mental illness is “cool.” Their efforts may not help the young people but they sure help Pharma.

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

bernie-the-sandernistas-cover-344x550
April 08, 2020
Melvin Goodman
The Impact of COVID-19 on the Body Politic
Eve Ottenberg
Amid Plague, Sanctions are Genocide
Vijay Prashad, Du Xiaojun – Weiyan Zhu
How China Learned About SARS-CoV-2 in the Weeks Before the Global Pandemic
Bill Quigley
Seven Disturbing Facts About COVID-19 in Louisiana
Joyce Nelson
BlackRock Takes Command
Geoff Dutton
Coronavirus as Metaphor: It’s Not Peanuts
Richard Moser
From Strike Wave to General Strike
Gary Leupp
Could COVID-19 Kill Capitalism?
Thomas Klikauer – Nadine Campbell
Corona, Capital and Class in Germany
Tom Crofton
Aspirational vs Pragmatic: Why My Radicalness is Getting More Radical
Steve Kelly
Montana Ballot Access Decision Suppresses Green Party Voters
Jacob Hornberger
Muhammad Ali’s Fight Against the Pentagon
Phil Mattera
The Rap Sheets of the Big Ventilator Producers
Manuel García, Jr.
Why Remdesivir and Hydroxychloroquine for COVID-19?
Rick Baum
When “Moderate” Democrats Lead the Ticket and Win, Down-Ballot Candidates Soon Suffer Losses
Jake Johnston
Tens of Millions Will Be Pushed into Poverty Amid COVID-Induced Recession
Kim C. Domenico
Healthy and Unhealthy Fear in the Age of Coronavirus
John W. Whitehead
Draconian Lockdown Powers and Civil Liberties
Binoy Kampmark
University Bailouts, Funding and Coronavirus
Luke Ruediger
BLM Timber Sale Increases Fire Risk, Reduces Climate Resilience and Harms Recreation
John Kendall Hawkins
Slavoj Žižek’s Virulent Polemic Against Covid-19, and Stuff!
Nyla Ali Khan
Finding Meaning and Purpose in Adversity
April 07, 2020
Joel McCleary – Mark Medish
Paradigm Shift by Pandemic
Matt Smith
Amazon Retaliation: Workers Striking Back
Kenneth Surin
What The President Said (About The Plague)
Patrick Cockburn
The Chaotic Government Response to COVID-19 Resembles the Failures of 1914
Marshall Auerback
The Coronavirus Pandemic Has Opened the Curtains on the World’s Next Economic Model
Vijay Prashad, Paola Estrada, Ana Maldonado, and Zoe PC
Trump Sends Gun Boats to Venezuela While the World Partners to Fight a Deadly Pandemic
Jeremy Lent
Coronavirus Spells the End of the Neoliberal Era. What’s Next?
Dean Baker
The Big Hit: COVID-19 and the Economy
Nino Pagliccia
A Simple Democratic Transition Framework for Venezuela: End All “Sanctions”
Colin Todhunter
Locked Down and Locking in the New Global Order
Robert Fisk
Biden Says He ‘Doesn’t Have Enough Information’ on Iran to Have a Vew. How Odd, He Negotiated the Nuclear Deal
Wim Laven
GOP’s Achievement is Now on Display
Binoy Kampmark
Boastful Pay Cuts: the Coronavirus Incentive
Dave Lindorff
It’s Spring and I’ve Turned 71 in a Pandemic-Induced Recession
Steve Brown
FLASH! Trump Just Endorsed Bernie’s Medicare-For-All Health Plan
Marc Haggerty
Class and COVID-19: Those Who Can and Those Who Can’t
Manuel García, Jr.
A Reply to Jeffrey St. Clair’s “Strange Things Happening Every Day”
George Wuerthner
How Fuel Breaks Fuel Fires
Marshall Sahlins
Election 2020
April 06, 2020
Richard D. Wolff
COVID-19 and the Failures of Capitalism
W. T. Whitney
Donald Trump, Capitalism, and Letting Them Die
Cesar Chelala
Cuba’s Promising Approach to Cancer
David A. Schultz
Camus and Kübler-Ross in a Time of COVID-19 and Trump
FacebookTwitterRedditEmail